Previse is a life sciences company focused on the development and commercialization of diagnostic tests for cancer prevention.
Previse has raised $1.8M in total funding. The most recent round was Grant. The last funding was announced in October 2024.
Previse's investors include Gaingels, TEDCO, National Cancer Institute, Wexford Science & Technology, Riptide Ventures.
Previse is headquartered in Baltimore, United States.
Previse is a life sciences company focused on the development and commercialization of diagnostic tests for cancer prevention.
Previse is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Previse — Funding & Investors." VCBacked, October 22, 2024, https://www.vcbacked.co/company/previse. Accessed November 13, 2026.
VCBacked. (2024). Previse — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/previse
{{cite web |title=Previse — Funding & Investors |url=https://www.vcbacked.co/company/previse |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Previse? Request a listing update